UY27124A1 - HISTAMINE RECEIVER ANTAGONISTS - Google Patents

HISTAMINE RECEIVER ANTAGONISTS

Info

Publication number
UY27124A1
UY27124A1 UY27124A UY27124A UY27124A1 UY 27124 A1 UY27124 A1 UY 27124A1 UY 27124 A UY27124 A UY 27124A UY 27124 A UY27124 A UY 27124A UY 27124 A1 UY27124 A1 UY 27124A1
Authority
UY
Uruguay
Prior art keywords
histamine
receptor
receiver antagonists
histamine receiver
antagonists
Prior art date
Application number
UY27124A
Other languages
Spanish (es)
Inventor
Stephen Jenkinson
Mark A O'reilly
Michael A Trevethick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to UY27124A priority Critical patent/UY27124A1/en
Publication of UY27124A1 publication Critical patent/UY27124A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona una combinación de (a) un antagonista de receptor H1 de histamina y (b) un antagonista que es al menos 10 veces más selectivo para el receptor H4 de histamina en comparación con el receptor H3 de histamina; y un antagonista que es al menos 10 veces más selectivo para el receptor H4 de histamina en comparación con el receptor H3 de histamina; y sus composiciones y usos.The present invention provides a combination of (a) a histamine H1 receptor antagonist and (b) an antagonist that is at least 10 times more selective for the histamine H4 receptor compared to the histamine H3 receptor; and an antagonist that is at least 10 times more selective for the histamine H4 receptor compared to the histamine H3 receptor; and its compositions and uses.

UY27124A 2002-01-14 2002-01-14 HISTAMINE RECEIVER ANTAGONISTS UY27124A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27124A UY27124A1 (en) 2002-01-14 2002-01-14 HISTAMINE RECEIVER ANTAGONISTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27124A UY27124A1 (en) 2002-01-14 2002-01-14 HISTAMINE RECEIVER ANTAGONISTS

Publications (1)

Publication Number Publication Date
UY27124A1 true UY27124A1 (en) 2002-08-30

Family

ID=38812566

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27124A UY27124A1 (en) 2002-01-14 2002-01-14 HISTAMINE RECEIVER ANTAGONISTS

Country Status (1)

Country Link
UY (1) UY27124A1 (en)

Similar Documents

Publication Publication Date Title
ECSP045274A (en) N-AMINOACETIL-PIRROLIDINA-2-CARBONITRILOS AND ITS USE AS DDP-IV INHIBITORS
PA8527201A1 (en) CYCLED PEPTIDES WITH AGONIST ACTIVITY FOR THE RECEIVER OF MELANOCORTIN-4 (MC4-R)
PA8567001A1 (en) ZIPRASIDONE COMPOSITION AND SYNTHETIC CONTROLS
DK1379239T3 (en) N (2-aryl-ethyl) -benzylamines as antagonists of the HT6 receptor
ECSP066710A (en) MUTANTS OF ANTIBODY ANTI-CD40
PA8493401A1 (en) USE OF CYP2D6 INHIBITORS IN COMBINATION THERAPIES
BR9911621A (en) Biphenyl sulfonamides as dual angiotensin receptor endothelin antagonist
AU3652102A (en) Compounds and their uses
BRPI0413922A (en) substituted 8-heteroaryl xanthines
EA199900630A1 (en) ANTAGONISTS OF VITRONECTIN RECEPTORS
ECSP055888A (en) DERIVATIVES OF ARIL-QUINAZOLIN / ARIL-2-AMINO-FENIL METANONA THAT PROMOTE THE RELEASE OF PARTIROID HORMONE.
BR0206595A (en) Compound, pharmaceutical composition, and use of a compound
CL2004000449A1 (en) COMPOUNDS DERIVED FROM IMIDAZOL-4-IL-ETINIL-PIRIDINA, TO TREAT DISORDERS MEDIATED BY THE RECEIVER MGLUR5; COMPOUND PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES ONE OF THE COMPOUNDS; AND USE OF COMPOUNDS IN
UY27800A1 (en) USE OF SENAL TRANSDUCTION INHIBITORS INDIRECTED BY EGFR FOR THE TREATMENT OF HYPERPLASIA OF THE BENIGNA PROSTATE (HPS) / PROSTATE HYPERTROPHY.
HN2002000299A (en) DERIVATIVES OF 3- AZABICICLO [3.1.0] HEXANO
DK1313485T3 (en) Use of an aldosterone receptor antagonist to improve cognitive function
ECSP034531A (en) SUBSTITUTED DERIVATIVES OF C-CICLOHEXILMETILAMINA
ECSP034692A (en) HISTAMINE RECEIVER ANTAGONISTS
UY28148A1 (en) SCITALOPRAM BROMHYDRATE AND A METHOD FOR PREPARATION
ES2162493T3 (en) METHOD FOR THE FIGHT OF OBESITY.
UY27124A1 (en) HISTAMINE RECEIVER ANTAGONISTS
CY1107415T1 (en) PHARMACEUTICAL COMPOSITION WHICH COMBINES TENATOPROZOL AND A COMPETENT OF HISTAMIN H2 RECEPTORS
PT1406888E (en) SUBSTITUTED Y-LACTONE COMPOUNDS THAT SERVE AS NMDA ANTAGONISTS
PE20040868A1 (en) NEW COMBINATION OF TYPE 5 PHOSPHODIESTERASE INHIBITOR (PDE5) AND ANGIOTENSIN II RECEPTOR ANTAGONIST
BR0313307A (en) Mcp-1 receptor antagonists and method for their use

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160623